On Friday, uniQure N.V (NASDAQ: QURE) opened higher 3.05% from the last session, before settling in for the closing price of $13.78. Price fluctuations for QURE have ranged from $3.73 to $19.18 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 323.68% over the past five years. Company’s average yearly earnings per share was noted 20.86% at the time writing. With a float of $47.24 million, this company’s outstanding shares have now reached $48.99 million.
Let’s look at the performance matrix of the company that is accounted for 209 employees. In terms of profitability, gross margin is 12.88%, operating margin of -696.25%, and the pretax margin is -874.39%.
uniQure N.V (QURE) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of uniQure N.V is 12.63%, while institutional ownership is 75.95%. The most recent insider transaction that took place on Mar 04 ’25, was worth 291,629. In this transaction CEO, Managing Director of this company sold 28,341 shares at a rate of $10.29, taking the stock ownership to the 651,454 shares. Before that another transaction happened on Mar 04 ’25, when Company’s Chief Medical Officer sold 1,350 for $10.29, making the entire transaction worth $13,891. This insider now owns 151,903 shares in total.
uniQure N.V (QURE) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.97 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.86% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.66% during the next five years compared to -9.66% drop over the previous five years of trading.
uniQure N.V (NASDAQ: QURE) Trading Performance Indicators
Check out the current performance indicators for uniQure N.V (QURE). In the past quarter, the stock posted a quick ratio of 9.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 28.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.92, a number that is poised to hit -0.98 in the next quarter and is forecasted to reach -3.04 in one year’s time.
Technical Analysis of uniQure N.V (QURE)
uniQure N.V (NASDAQ: QURE) saw its 5-day average volume 0.91 million, a negative change from its year-to-date volume of 1.02 million. As of the previous 9 days, the stock’s Stochastic %D was 91.04%. Additionally, its Average True Range was 1.11.
During the past 100 days, uniQure N.V’s (QURE) raw stochastic average was set at 63.99%, which indicates a significant decrease from 89.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 108.47% in the past 14 days, which was lower than the 148.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.21, while its 200-day Moving Average is $8.87. Nevertheless, the first resistance level for the watch stands at $14.63 in the near term. At $15.07, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.45. If the price goes on to break the first support level at $13.81, it is likely to go to the next support level at $13.43. The third support level lies at $12.99 if the price breaches the second support level.
uniQure N.V (NASDAQ: QURE) Key Stats
There are currently 54,077K shares outstanding in the company with a market cap of 767.89 million. Presently, the company’s annual sales total 27,120 K according to its annual income of -239,560 K. Last quarter, the company’s sales amounted to 5,220 K and its income totaled -73,260 K.
